Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

What benefit can we expect from emerging targeted agents including ICI to improve survival?

Date

30 Sep 2019

Session

ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival?

Presenters

Margaret Tempero

Authors

M.A. Tempero

Author affiliations

  • UCSF Helen Diller Family Comprehensive Cancer Center, 94115 - San Francisco/US
More

Resources

Reserved to ESMO members
View the presentation

Resources from the same session

How can surgery improve resectability criteria?

Presenter: Massimo Falconi

Session: ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival?

Resources:

Presentation

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings